baber/WOPTO huggingface dataset:
Patent MX-2019015705-A (MX)
Title: Methods of packaging and preserving crustaceans.
Inventor: FREEDMAN JONATHAN R
IPC: B65D85/50
Filed: 2018-06-29
Abstract: Methods are provided for storing and preserving comestible crustacean material, preferably so as to extend shelf life of the same. In one optional method, comestible crustacean material is placed in a product containing space of a storage container atop a platform of a support structure. The storage container includes an internal compartment having the product containing space. The support structure defines the platform for supporting the comestible crustacean material. The internal compartment further includes a reservoir, configured to retain liquid, below the platform. The platform and/or support structure are configured to direct liquid exuded from the comestible crustacean material to the reservoir. Optionally, the reservoir comprises an absorbent material for absorbing liquid in the reservoir.
Patent MX-2020004775-A (MX)
Inventor: ANTONELLINI VINCENT
IPC: B65D5/66
Filed: 2018-11-15
Abstract: Un contenedor (10) para bienes de consumo comprende: una caja (12) para alojar los bienes de consumo, la caja (12) comprende una pared frontal de la caja (18), una pared trasera de la caja (20), una pared inferior de la caja y paredes laterales de la caja (22), en donde la cara superior de la caja (12) está al menos parcialmente abierta para proporcionar una abertura de acceso para acceder a los bienes de consumo; y una aleta de la tapa (14) conectada de manera abatible a la pared trasera de la caja (20) y que comprende una pared superior de la tapa (30) y una pared frontal de la tapa (32). En una posición cerrada de la aleta de la tapa (14), la pared superior de la tapa (30) y la pared frontal de la tapa (32) se superponen a la abertura de acceso y la pared frontal de la caja (18). Antes de la primera apertura del contenedor (10), al menos una pared de la aleta de la tapa (14) está conectada a una pared de la caja (12) a lo largo de una línea de debilidad (38), en donde, tras la separación de la aleta de la tapa (14) desde la caja (12) a lo largo de la línea de debilidad (38), la aleta de la tapa (14) se puede mover a una posición abierta en la que se descubre la abertura de acceso.
Patent MX-2020005131-A (MX)
Title: Drug delivery apparatus.
Inventor: BOISDON OLIVIER
IPC: A61M5/315
Filed: 2018-11-15
Abstract: A drug delivery apparatus including a barrel to contain a substance, a piston slidable in the barrel, a supply circuit to provide input currents, an antenna affixed along the barrel to receive the input current, generate inductance with the piston, and provide output currents commensurate with a position of the piston along the piston course, and processing circuitry configured to receive the output currents, and determine a quantity of the substance inside the barrel based on the output currents.
Patent MX-2020005830-A (MX)
Title: Non-human animals having an engineered immunoglobulin lambda light chain and uses thereof.
Inventor: MCWHIRTER JOHN
IPC: C12N9/12
Filed: 2018-12-04
Abstract: Non-human animals (and/or non-human cells) and methods of using the same are provided, which non-human animals (and/or non-human cells) have a genome comprising human antibody-encoding sequences (i.e., immunoglobulin genes). Non-human animals described herein express antibodies that contain immunoglobulin (Ig) light chains characterized by the presence of human VÎ» domains. Non-human animals provided herein are, in some embodiments, characterized by expression of antibodies that contain human VÎ» light chains that are encoded by human IgÎ» light chain-encoding sequences inserted into an endogenous IgÎº light chain locus of said non-human animals. Methods for producing antibodies from non-human animals are also provided, which antibodies contain human variable regions and mouse constant regions.
Patent MX-2020006840-A (MX)
Title: Pharmaceutical composition comprising an apl peptide.
Inventor: LOPEZ ABAD CRUZ MATILDE
IPC: A61P29/00
Filed: 2018-12-21
Abstract: The invention relates to a pharmaceutical composition comprising the APL peptide of SEQ ID No. 1, the sodium acetate buffer with a pH of 3.9-4.7, and at least one stabilising sugar selected from saccharose and trehalose. This pharmaceutical composition is useful for the treatment of inflammatory diseases associated with an increase of neutrophils or protein citrullination. These inflammatory diseases include rheumatoid arthritis (RA), juvenile chronic arthritis (JCA), ankylosing spondylitis (AS), Alzheimer's disease and hepatic or pulmonary fibrosis. The invention also relates to a method for the treatment of these diseases by administration of a therapeutically effective dose of the pharmaceutical composition of the APL peptide of SEQ ID No. 1.
Patent MX-2020007646-A (MX)
Title: Processes for the synthesis of sulfentrazone.
Inventor: LI GUANGHUI
IPC: C07D249/12
Filed: 2019-01-18
Abstract: Disclosed are processes for the synthesis of sulfentrazone, which provide a high conversion of sulfentrazone amine and high yield of the final sulfentrazone product.
Patent MX-2020007749-A (MX)
Title: Emergency wheel.
Inventor: TSIBERIDIS KONSTANTIN
IPC: B60B11/10
Filed: 2019-01-18
Abstract: The invention relates to attachments (14) for a vehicle wheel (1) which comprises a rim (2) and a tyre (3) arranged on the rim (2), wherein the attachments (14) are designed to enable in an operating state, in which they are fastened to the vehicle wheel (1), a driving operation while the tyre function is restricted. The invention further relates to tensioning means (22) for such attachments (14).
Patent MX-2020007753-A (MX)
Title: Sealable resin composition, seal material, packaging material, packaging container and package.
Inventor: ISHIHARA TAKUYA
IPC: C09K3/10
Filed: 2019-01-16
Abstract: This sealable resin composition contains an ethylene/unsaturated ester copolymer (A) and an acid-modified styrene copolymer (B). Defining the total content of the ethylene/unsaturated ester copolymer (A) and the acid-modified styrene copolymer (B) as 100 mass%, the content of the ethylene/unsaturated ester copolymer (A) is 60-99 mass% and the content of the acid-modified styrene copolymer (B) is 1-40 mass%, and the amount of extraction into n-hexane is less than or equal to 100 mg/L.
Patent MX-2020009582-A (MX)
Title: Vacuum refining of molten glass.
Inventor: WANG ZHONGMING
IPC: C03B5/225
Filed: 2019-03-12
Abstract: An apparatus (10) and method of refining molten glass are disclosed. An upstream vessel (12) contains molten glass, a downstream vessel (14) is arranged downstream of the upstream vessel, and vacuum refining vessels (16, 18) are located between the upstream vessel and the downstream vessel and are in separate, alternating fluid communication with the upstream vessel and in separate, alternating fluid communication with the downstream vessel.
Patent MX-2020012573-A (MX)
Title: Chimeric antigen receptors targeting b-cell maturation antigen.
Inventor: GALETTO ROMAN
IPC: C07K14/705
Filed: 2017-10-13
Abstract: The invention provides Chimeric Antigen Receptors (CARs) that specifically bind to BCMA (B-Cell Maturation Antigen). The invention further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The invention further relates to therapeutic methods for use of these CARs and engineered immune cells for the treatment of a condition associated with malignant cells expressing BCMA (e.g., cancer).
Patent MX-2020012906-A (MX)
Title: Systems and methods for dataflow graph optimization.
Inventor: DICKIE GARTH ALLEN
IPC: G06F8/41
Filed: 2019-05-22
Abstract: At least one non-transitory computer-readable storage medium storing processor- executable instructions that, when executed by at least one computer hardware processor, cause the at least one computer hardware processor to perform: obtaining an automatically generated initial dataflow graph, the initial dataflow graph comprising a first plurality of nodes representing a first plurality of data processing operations and a first plurality of links representing flows of data among nodes in the first plurality of nodes; and generating an updated dataflow graph by iteratively applying dataflow graph optimization rules to update the initial dataflow graph, the updated dataflow graph comprising a second plurality of nodes representing a second plurality of data processing operations and a second plurality of links representing flows of data among nodes in the second plurality of nodes.
Patent MX-2021000455-A (MX)
Title: Plate electrodes.
Inventor: VELASCO VALCKE FRANCISCO JAVIER
IPC: A61N1/18
Filed: 2019-07-16
Abstract: The present disclosure relates to electrodes for electrical tissue stimulation and to methods for electrical tissue stimulation and administration of substances to the tissue using the electrode. In particular, the disclosure teaches an electrode comprising a first conductive plate and a second conductive plate surrounding the first conductive plate, wherein the first conductive plate and the second conductive plate are separated from each other. Also taught is a method for inducing an electrical current in a tissue using an electrical tissue stimulation electrode, wherein an activation signal is applied to a first conductive plate of the electrode to generate an electric field that induces a current in the tissue and to apply an electrical potential to a second conductive plate of the electrode in order to obtain an electric potential differential with respect to the first conductive plate, the electric potential of the second conductive plate forcing the current induced by the first plate of conductive material to penetrate the tissue surface in contact with the conductive plates and prevent the induced current from flowing along the tissue surface. Also disclosed is a method for supplying an ionically charged substance using the electrode taught in this document, which comprises a step of disposing a substance on the tissue, wherein, when an electric field is applied with sufficient force and duration, the tissue cell walls become temporarily permeable and allow the substance to pass therethrough without damaging the tissue cells.
Patent MX-2021003020-A (MX)
Title: Orally dissolving mucoadhesive films utilizing menthol and l-arginine to enhance the bioavailability of cannabinoids.
Inventor: THOMPSON RONALD J
IPC: A61K31/05
Filed: 2019-09-12
Abstract: A method for providing an orally dissolvable composition of menthol, l-arginine and one or more cannabinoids for quickly and reliably providing enhanced pharmacokinetic bioavailability of the cannabinoids to a mammalian subject. The orally dissolvable composition is preferably in the form of a thin orally dissolving mucoadhesive strip or film that is placed in the buccal cavity or under the tongue of a user. The menthol and l-arginine function as permeation enhancers and local vasodilators, providing improved oral transmucosal absorption of the cannabinoids.
Patent MX-2021004712-A (MX)
Title: System and method for a six-primary wide gamut color system.
Inventor: MANDLE GARY B
IPC: G02B30/00
Filed: 2019-10-22
Abstract: Systems and methods for a six-primary color system for display. A six-primary color system increases the number of primary colors available in a color system and color system equipment. Increasing the number of primary colors reduces metameric errors from viewer to viewer. The six-primary color system includes Red, Green, Blue, Cyan, Yellow, and Magenta primaries. The systems of the present invention maintain compatibility with existing color systems and equipment and provide systems for backwards compatibility with older color systems.
Patent MX-2021005093-A (MX)
Title: Controlling plants by means of electrical energy.
Inventor: HADLOW JAMES
IPC: A01M21/04
Filed: 2019-10-28
Abstract: The present invention relates to the control of plants which appear as undesirable matter in a field for crop plants by means of electrical energy. The subject matter of the present invention is a method, a device and a vehicle for controlling plants.
Patent MX-2021007084-A (MX)
Title: An antimicrobial composition.
Inventor: MAJUMDAR AMITABHA
IPC: A61Q5/00
Filed: 2019-11-26
Abstract: The present invention relates to an antimicrobial composition. More particularly the present invention relates to an antimicrobial composition for malodor and oral biofilm inhibitions benefits. Accordingly, the present invention provides an antimicrobial composition comprising: a. 0.1 to 10% by weight of tetrahydroxypropyl ethylenediamine (THPE) and, b. 0.001 to 10% by weight of at least one compound selected from a biphenol.
Patent MX-2021009993-A (MX)
Title: Methods and devices for localizing compositions.
Inventor: GIBSON HAL WILLIAM
IPC: A61K8/64
Filed: 2020-02-20
Abstract: The present Specification relates to methods and devices for localizing injected materials within the body.
Patent MX-2021013694-A (MX)
Title: Dental mouthpiece.
Inventor: NGUYEN THIEN
IPC: A61B1/24
Filed: 2020-05-08
Abstract: A dental mouthpiece is provided that may be attached to a high-suction dental adapter for the purpose of assisting the dental staff during dental procedures through chair-side, hands-free suction, and isolation. Such a mouthpiece may comprise a main body portion, a cheek retractor portion, and a suction connector portion. In an embodiment, the main body portion, cheek retractor portion, and suction connector portion may be molded in one piece, preferably by injection molding. The main body portion has an anterior wall inside the curve and a posterior wall outside the curve, and an at least one connector connecting the anterior wall and the posterior wall. The main body portion has an anterior intervening wall and the posterior intervening wall in between the anterior and posterior walls. The anterior intervening wall and the posterior intervening walls have alternating crests and troughs.
Patent MX-2021013709-A (MX)
Title: Quantum vacuum fluctuation devices.
Inventor: MODDEL GARRET
IPC: H02N11/00
Filed: 2020-05-05
Abstract: Described herein are devices incorporating Casimir cavities, which modify the quantum vacuum mode distribution within the cavities. The Casimir cavities can drive charge carriers from or to an electronic device disposed adjacent to or contiguous with the Casimir cavity by modifying the quantum vacuum mode distribution incident on one side of the electronic device to be different from the quantum vacuum mode distribution incident on the other side of the electronic device. The electronic device can exhibit a structure that permits transport or capture of hot carriers in very short time intervals, such as in 1 picosecond or less.
Patent MX-2021014220-A (MX)
Title: Compositions for the treatment of hair loss.
Inventor: WURST JOHN EDWARD
IPC: A61P17/14
Filed: 2020-08-03
Abstract: Compositions and methods for the treatment of hair growth and the prevention of hair loss.
Patent MX-2021014519-A (MX)
Title: Selective chemical fining of small bubbles in glass.
Inventor: SMITH ROGER P
IPC: C03B5/225
Filed: 2020-09-30
Abstract: A method of lining glass is disclosed that includes flowing a molten glass bath (22) through a fining chamber (20). The molten glass bath (22) has an undercurrent (62) that flows beneath a skimmer (50) that is partially submerged in the molten glass bath (22). One or more fining agents are introduced into the undercurrent (62) of the molten glass bath (22) directly beneath the skimmer (50) from a carrier gas (68). in this way, the fining agent(s) may selectively target the gas bubbles (82) drawn under the skimmer (50) within the undercurrent (62) of the molten glass bath (22) for removal. The method may be employed to fine molten glass produced in a submerged combustion melter (14). A fining vessel (10) for fining molten glass is also disclosed.
Patent MX-2021015772-A (MX)
Title: Novel carbonate compound having pyrrolopyrimidine skeleton or pharmaceutically acceptable salt thereof.
Inventor: KOBAYAKAWA Yu
IPC: A61P35/00
Filed: 2020-06-17
Abstract: [Problem] To provide: a novel carbonate compound of nucleotides which has a pyrrolopyrimidine skeleton and exhibits an excellent antitumor effect, or a pharmaceutically acceptable salt thereof; and a method for preventing and/or treating tumor by being used in combination with an alkylating agent and/or radiotherapy. [Solution] According to an aspect of the present invention, provided are: a compound represented by general formula (1) or a pharmaceutically acceptable salt; and a method for preventing and/or treating tumor by being used in combination with an alkylating agent and/or radiotherapy.
Patent MX-2021015989-A (MX)
Title: Processing and purification of carbonaceous materials.
Inventor: KAISER CHRISTIAN
IPC: C01B32/05
Filed: 2020-07-08
Abstract: The present invention relates to a process for the processing and/or purification of carbon black comprising the steps of: a) providing carbon black containing impurities b) providing an aqueous fluid comprising a nitrogen hydride c) providing an alkali metal hydroxide and/or an alkali metal d) contacting the mixture of step a), the fluid of step b) and the alkali metal hydroxide and/or alkali metal of step c) e) subjecting the composition obtained in step d) to an elevated temperature in the range of 80 to 240Â°C and an elevated pressure in the range of 5 to 50 bar f) separating a carbonaceous solid from the composition obtained in step e). The present invention further relates to the use of a nitrogen hydride as a dispersing agent for producing and/or stabilizing an aqueous suspension.
Patent MX-2022001865-A (MX)
Title: Articles and methods for administration of therapeutic agents.
Inventor: TRAVERSO CARLO GIOVANNI
IPC: A61K31/375
Filed: 2020-08-12
Abstract: Articles and methods for delivering a therapeutic agent to a subject are described. These articles and methods may be useful, in some cases, for the delivery of therapeutic agents to the colon of a subject. In some embodiments, an article is configured to release a secretion inducing agent e.g., to stimulate the release of intestinal fluids. The article, in some embodiments, comprises a therapeutic agent such that the stimulated release of intestinal fluid increases the amount of therapeutic agent available for absorption by the colon. For example, in some embodiments, the articles and methods described herein advantageously promote increased absorption of therapeutic agents in subjects as compared to traditionally administered therapeutic agents without additional components such as a secretion inducing agent. In some embodiments, articles and methods described herein may increase the motility of the colon of a subject. The increase in contractions and movement of fluidic in the colon caused by increase motility may advantageously facilitate the dissolution or absorption of the therapeutic agent.
Patent MX-2022003351-A (MX)
Title: Apparatus for handling value documents.
Inventor: DÜSTERHUS RICHARD
IPC: G07D11/14
Filed: 2020-09-24
Abstract: The invention relates to a device for handling value documents, comprising a value document dispensing unit (16) with a dispensing compartment (72) for dispensing value documents (28, 48, 50) and with a first closure element (60) which in a closed position delimits the dispensing compartment (72) on one side. The first closure element (60) is movable from the closed position into an open position to open the dispensing compartment (72), and is movable from the open position into the closed position to close the dispensing compartment (72). The device comprises at least one second closure element (260), which is movable from an open position into a closed position and from the closed position into the open position. The second closure element (260) is arranged in such a way that access to value documents (28, 48, 50) provided in the dispensing compartment (72) is only possible if both the first closure element (60) and the second closure element (260) are in their open positions.
Patent MX-2022003645-A (MX)
Title: Vascular and aortic grafts and deployment tools.
Inventor: JEN JIMMY
IPC: A61F2/07
Filed: 2019-12-30
Abstract: A vascular graft deployment tool may include a grip, an elongated mandrel positioned distal of the grip, a vascular graft, at least part of which is disposed coaxially about the mandrel, a sheath assembly including a distal sheath portion and a proximal sheath potion, wherein the distal sheath portion and the proximal sheath portion are configured to constrain the vascular graft against the mandrel in an insertion diameter and an actuator that is moveable relative to the grip and engages the sheath assembly, wherein operation of the actuator causes at least one of the distal sheath portion and the proximal sheath portion to separate longitudinally to free at least a portion of the vascular graft. Further, a vascular graft is expandable from an insertion state to a deployed state and at least two suture cuffs are located between opposed ends of the vascular graft.
Patent MX-2022004362-A (MX)
Title: Shoulder protected drilling assembly.
Inventor: HAMMARGREN JOHN
IPC: E21B17/04
Filed: 2020-10-09
Abstract: A drilling assembly for percussive drilling, comprising at least two of a drill bit, a drill rod and a guide adapter; wherein the peripheral surface of the shoulder on the drill rod is at least partially encased in both radial and axial directions inside the mounting sleeve of the drill bit or the mounting sleeve of the guide adapter; and / or the peripheral surface of the shoulder on the guide adapter is at least partially encased in both radial and axial directions inside the mounting sleeve of the drill bit.
Patent MX-2022007332-A (MX)
Title: Transmucosal therapeutic system containing agomelatine.
Inventor: MOHR PATRICK
IPC: A61K9/00
Filed: 2020-10-02
Abstract: The present invention relates to transmucosal therapeutic systems for the transmucosal administration of agomelatine comprising a mucoadhesive layer structure comprising a therapeutically effective amount of agomelatine, such agomelatine transmucosal therapeutic systems for use in a method of treatment, a method of treatment comprising applying such agomelatine transmucosal therapeutic systems, and processes of manufacture of such transmucosal therapeutic systems.
Patent MX-2022008840-A (MX)
Title: System and method for predicting the risk of future lung cancer.
Inventor: WASHKO JR GEORGE R
IPC: G06T7/00
Filed: 2021-01-15
Abstract: Risk prediction models are trained and deployed to analyze images, such as computed tomography scans, for predicting future risk of lung cancer for one or more subjects. Individual risk prediction models are separately trained on nodule- specific and non-nodule specific features such that each risk prediction model can predict future risk of lung cancer acros different time periods (e.g., 1 year, 3 years, or 5 years). Such risk prediction models are useful for developing preventive therapies for lung cancer by enabling clinical trial enrichment.
Patent MX-2022011862-A (MX)
Title: Method for treatment of neurological disorders using synaptic pathway training.
Inventor: RUSTICK JOSEPH
IPC: A61K31/135
Filed: 2021-03-16
Abstract: Disclosed are methods of treating depression, mania, post-traumatic stress disorder (PTSD), and various other neurologic conditions using synaptic pathway training. Methods of synaptic pathway training include, generally, achieving a favorable treatment result by activating a synaptic pathway using a pharmacologic agent, such as treating refractory symptoms of depression with ketamine, following by potentiation of the favorable result by repeatedly stimulating the activated pathway. Stimulation of a synaptic pathway may be achieved by intrinsic means, such as performance of cognitive exercised, or extrinsic means, such as by delivery of a sensory stimulus to the patient, placing a potential voltage difference across the brain or a brain region, or by placing the brain or a brain region in a magnetic field.